90.74
price down icon2.12%   -1.97
after-market アフターアワーズ: 91.36 0.62 +0.68%
loading
前日終値:
$92.71
開ける:
$93.29
24時間の取引高:
9.60M
Relative Volume:
0.75
時価総額:
$158.05B
収益:
$45.13B
当期純損益:
$6.28B
株価収益率:
25.28
EPS:
3.5895
ネットキャッシュフロー:
$7.38B
1週間 パフォーマンス:
+0.23%
1か月 パフォーマンス:
+6.00%
6か月 パフォーマンス:
-27.58%
1年 パフォーマンス:
-33.28%
1日の値動き範囲:
Value
$90.61
$93.29
1週間の範囲:
Value
$90.28
$95.21
52週間の値動き範囲:
Value
$81.97
$137.49

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1095)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
115,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2026-07-16
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

Compare ABT vs SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ABT icon
ABT
Abbott Laboratories
90.74 163.94B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
314.84 127.55B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
78.23 103.66B 36.36B 4.84B 5.43B 3.7212
BSX icon
BSX
Boston Scientific Corp
42.68 65.74B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
90.46 52.27B 6.30B 1.07B 1.09B 1.8406

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-22 ダウングレード Daiwa Securities Outperform → Neutral
2025-10-10 開始されました The Benchmark Company Buy
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Jun 30, 2026

Abbott Laboratories stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 30, 2026
pulisher
Jun 30, 2026

US criminal probe into Abbott infant-formula plant closed - Global Food Industry News

Jun 30, 2026
pulisher
Jun 30, 2026

Trump Admin Stopped Criminal Charges Against Abbott Nutrition for Infant Formula Illnesses - Food Safety Magazine

Jun 30, 2026
pulisher
Jun 30, 2026

Abbott Laboratories earnings calendar, shares in focus on the NYSE - AD HOC NEWS

Jun 30, 2026
pulisher
Jun 29, 2026

Abbott Laboratories was investigated for poisoning babies. After a $500,000 donation, Trump let them off the hook. - More Perfect Union | Substack

Jun 29, 2026
pulisher
Jun 29, 2026

Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo! Finance Canada

Jun 29, 2026
pulisher
Jun 29, 2026

Form 4 Abbott Laboratories For: 29 June By Investing.com - Investing.com Canada

Jun 29, 2026
pulisher
Jun 29, 2026

Abbott (ABT) EVP Cushman disposes 560 shares for tax withholding, retains 38,013 - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch

Jun 29, 2026
pulisher
Jun 29, 2026

Coca Cola Stock And 2 Defensive Picks For Steady Dividends - simplywall.st

Jun 29, 2026
pulisher
Jun 29, 2026

MDL Sought for Abbott Spinal Cord Stimulator Lawsuits - AboutLawsuits.com

Jun 29, 2026
pulisher
Jun 29, 2026

How Abbott's Largest Segment Is Preparing for the Next Growth Phase - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Abbott Laboratories dropped from Russell Top 50, shares hold above Tradegate level - AD HOC NEWS

Jun 29, 2026
pulisher
Jun 29, 2026

Abbott Laboratories (ABT) Criminal Probe Closed by Justice Depar - GuruFocus

Jun 29, 2026
pulisher
Jun 29, 2026

U.S. Justice Department Closes Criminal Probe into Abbott Laboratories - Intellectia AI

Jun 29, 2026
pulisher
Jun 29, 2026

DOJ dropped Abbott baby formula criminal probe despite pile of evidence: WSJ (ABT:NYSE) - Seeking Alpha

Jun 29, 2026
pulisher
Jun 28, 2026

US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports - Reuters

Jun 28, 2026
pulisher
Jun 28, 2026

Exclusive | The Baby Formula Probe Produced a Pile of Evidence. Then the DOJ Dropped the Case. - WSJ

Jun 28, 2026
pulisher
Jun 28, 2026

In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000 - The Motley Fool

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to revenue forward of Abbott Laboratories – NYSE:ABT - TradingView

Jun 28, 2026
pulisher
Jun 27, 2026

Abbott's Dual-Analyte Bet Positions It to Outpace Dexcom in the Expanding CGM Market - Kavout | AI

Jun 27, 2026
pulisher
Jun 27, 2026

Abbott Laboratories (ABT) must face a Lawsuit over PediaSure, Statements about Children’s Growth - Insider Monkey

Jun 27, 2026
pulisher
Jun 27, 2026

Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider - GlobeNewswire Inc.

Jun 27, 2026
pulisher
Jun 27, 2026

Abbott Laboratories (ABT) Stock After Recent Rebound Is There Still Value Left - Yahoo Finance

Jun 27, 2026
pulisher
Jun 26, 2026

Abbott Laboratories' Q2 2026 earnings: What to expect - MSN

Jun 26, 2026
pulisher
Jun 26, 2026

Abbott (ABT) Expands In Europe With Instinct CGM And Emerging Market Medicines - simplywall.st

Jun 26, 2026
pulisher
Jun 26, 2026

Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now? - The Globe and Mail

Jun 26, 2026
pulisher
Jun 26, 2026

Abbott Laboratories' Q2 2026 Earnings: What to Expect - Yahoo Finance

Jun 26, 2026
pulisher
Jun 26, 2026

Abbott Laboratories sets Q2 earnings date, shares trade firmly on NYSE - Ad-hoc-news.de

Jun 26, 2026
pulisher
Jun 26, 2026

Should you buy Abbott Labs stock hand over fist before July 16? - MSN

Jun 26, 2026
pulisher
Jun 25, 2026

Abbott shares drop amid sector rotation but growth in diabetes and devices signals buying opportunity. - Pluang

Jun 25, 2026
pulisher
Jun 25, 2026

Abbott Laboratories(NYSE: ABT) dropped from Russell Top 50 Index - marketscreener.com

Jun 25, 2026
pulisher
Jun 25, 2026

Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch

Jun 25, 2026
pulisher
Jun 25, 2026

Abbott Laboratories Stock (ABT) Moved Up by 3.12% on Jun 25: A Full Analysis - TradingKey

Jun 25, 2026
pulisher
Jun 25, 2026

Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy - AOL.com

Jun 25, 2026
pulisher
Jun 25, 2026

Price to sales forward of Abbott Laboratories – NYSE:ABT - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Abbott Laboratories highlights diagnostics growth, shares sit in the S&P 500 health cohort - Ad-hoc-news.de

Jun 25, 2026
pulisher
Jun 25, 2026

Price to sales forward of Abbott Laboratories – LSX:850103 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

$Abbott Laboratories (ABT.US)$ - Moomoo

Jun 25, 2026
pulisher
Jun 25, 2026

Abbott to post Q2 results July 16, then host live webcast - Stock Titan

Jun 25, 2026
pulisher
Jun 25, 2026

How An ALZpath Alzheimer’s Test Deal And Dividend Streak At Abbott (ABT) Has Changed Its Investment Story - simplywall.st

Jun 25, 2026
pulisher
Jun 25, 2026

How Does Wall Street View Abbott Laboratories (ABT)’s Outlook? - Insider Monkey

Jun 25, 2026
pulisher
Jun 24, 2026

ALZpath and Abbott Partner to Develop New Blood Test for Alzheimer’s Disease - Clinical Lab Products

Jun 24, 2026
pulisher
Jun 24, 2026

Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy - 24/7 Wall St.

Jun 24, 2026
pulisher
Jun 24, 2026

Abbott partners with ALZpath on Alzheimer’s blood test - grafa.com

Jun 24, 2026
pulisher
Jun 24, 2026

MiniMed Launches Abbott's Instinct Sensors Across European Markets - Yahoo Finance Singapore

Jun 24, 2026
pulisher
Jun 24, 2026

ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test - Reuters

Jun 24, 2026
pulisher
Jun 24, 2026

Abbott (ABT) Partners with ALZpath for Innovative Alzheimer's Di - GuruFocus

Jun 24, 2026
pulisher
Jun 24, 2026

Dividend Stocks That Could Hold Up Better If Rates Stay Higher For Longer - simplywall.st

Jun 24, 2026
pulisher
Jun 24, 2026

ALZpath licenses Alzheimer’s antibody to Abbott for diagnostic test - Investing.com

Jun 24, 2026
pulisher
Jun 24, 2026

ALZpath licenses Alzheimer’s antibody to Abbott for diagnostic test By Investing.com - Investing.com Canada

Jun 24, 2026

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
SYK SYK
$314.84
price down icon 4.74%
MDT MDT
$78.23
price down icon 3.34%
BSX BSX
$42.68
price down icon 1.84%
EW EW
$90.46
price down icon 0.79%
$64.01
price down icon 1.60%
大文字化:     |  ボリューム (24 時間):